These findings reveal ANXA6 as a modulator of autophagy‐driven radioresistance in NPC, acting through feedback regulation of the PI3K/AKT/mTOR pathway, and suggest its dual role as a potential biomarker and therapeutic target. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.